source
- Flagship launches Etcelera, an AI-driven biotech combining three platforms to predict drug effectsFlagship Pioneering announced the formation of Etcelera, a new biotech emerging from stealth that will focus on AI-powered drug discovery. The company brings together the technologies of Cellarity…
- GSK says UK restructuring will have limited impact on staff, focusing cuts on support rolesGSK executives said the company's global restructuring will only modestly affect UK staff, mainly targeting support functions at headquarters. CEO Luke Miels explained during the Q3 earnings call…